🇺🇸 FDA
Patent

US 10017551

Peptides having reduced toxicity that stimulate cholesterol efflux

granted A61KA61K38/17A61K45/06

Quick answer

US patent 10017551 (Peptides having reduced toxicity that stimulate cholesterol efflux) held by The Regents of the University of California expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/17, A61K45/06, A61K47/544, A61K47/64